News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
Presentation EuroPCR 2018 Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk Presenter: Lars Sondergaard May 25, 2018
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News EuroPCR 2017 TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years Caitlin E. Cox May 17, 2017
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Conference News EuroPCR 2015 New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak Yael L. Maxwell May 22, 2015
News Conference News EuroPCR 2015 NOTION: 2-Year Data Show Positive Outlook for TAVR in Lower-Risk Patients Yael L. Maxwell May 19, 2015